- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Integrating Palliative Care Into Oncology Practice
During this segment, Bruce Feinberg, DO, notes that oncologists commonly question the role of palliative care specialists, as oncologists consider pain management to be part of their job and are often concerned that referring patients to yet another type of oncology professional makes managing a patient’s disease more complex.
Ted Okon, MBA, executive director of the Community Oncology Alliance, remarks that not every patient needs to be referred to a palliative care specialist. Rather, he suggests that palliative care should be integrated into oncology practices.
Every healthcare professional within an oncology practice who contributes to a patient’s care needs to better understand what palliative care truly is, suggests Mr Okon. He adds that many people think that palliative care is end-of-life care, but it is not.
He advises that in many instances, the oncology practice can provide palliative care for patients, and that only patients in unique situations need a referral to a palliative care specialist.
Mr Okon says that the emphasis should always be placed on what is appropriate for the patient. “This is about the quality of life for the patient,” he adds.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More
